SELLAS Life Sciences Group annual depreciation and amortization
2010
2011
2012
2013
2014
2015
2016
SELLAS Life Sciences Group Depreciation & Amortization Growth & History (SLS)
SELLAS Life Sciences Group's depreciation and amortization was $3,000 for fiscal 2016.
View full SELLAS Life Sciences Group company overviewSELLAS Life Sciences Group annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2016 | 2016-12-31 | $3,000 | −$104,000 | −97.20% |
| 2015 | 2015-12-31 | $107,000 | $21,000 | +24.42% |
| 2014 | 2014-12-31 | $86,000 | −$200,000 | −69.93% |
| 2013 | 2013-12-31 | $286,000 | $237,000 | +483.67% |
| 2012 | 2012-12-31 | $49,000 | −$114,000 | −69.94% |
| 2011 | 2011-12-31 | $163,000 | −$9,000 | −5.23% |
| 2010 | 2010-12-31 | $172,000 | — | — |
SELLAS Life Sciences Group quarterly depreciation and amortization
Q3.10
Q1.11
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2017 | 2017-09-30 | $25,000 | −$5,000 | −16.67% |
| Q2 2017 | 2017-06-30 | $25,000 | −$34,000 | −57.63% |
| Q1 2017 | 2017-03-31 | $26,000 | $20,000 | +333.33% |
| Q3 2016 | 2016-09-30 | $30,000 | −$93,000 | −75.61% |
| Q2 2016 | 2016-06-30 | $59,000 | −$24,000 | −28.92% |
| Q1 2016 | 2016-03-31 | $6,000 | −$92,000 | −93.88% |
| Q3 2015 | 2015-09-30 | $123,000 | — | — |
| Q2 2015 | 2015-06-30 | $83,000 | −$146,000 | −63.76% |
| Q1 2015 | 2015-03-31 | $98,000 | −$134,000 | −57.76% |
| Q2 2014 | 2014-06-30 | $229,000 | $190,000 | +487.18% |
| Q1 2014 | 2014-03-31 | $232,000 | $230,000 | +11500.00% |
| Q3 2013 | 2013-09-30 | $127,000 | $124,000 | +4133.33% |
| Q2 2013 | 2013-06-30 | $39,000 | $37,000 | +1850.00% |
| Q1 2013 | 2013-03-31 | $2,000 | −$40,000 | −95.24% |
| Q3 2012 | 2012-09-30 | $3,000 | −$39,000 | −92.86% |
| Q2 2012 | 2012-06-30 | $2,000 | −$45,000 | −95.74% |
| Q1 2012 | 2012-03-31 | $42,000 | $5,000 | +13.51% |
| Q3 2011 | 2011-09-30 | $42,000 | $0 | 0.00% |
| Q2 2011 | 2011-06-30 | $47,000 | — | — |
| Q1 2011 | 2011-03-31 | $37,000 | — | — |
| Q3 2010 | 2010-09-30 | $42,000 | — | — |
SELLAS Life Sciences Group depreciation and amortization trends
Over the last five fiscal years, SELLAS Life Sciences Group's depreciation and amortization decreased from $163,000 to $3,000, a change of −$160,000. The latest reported quarter, Q3 2017, shows $25,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SELLAS Life Sciences Group source filings ↗